Pharm D Program: Is it Necessary in BRICS?

Abstract

The various trajectories of the development of the Doctor of Pharmacy (Pharm D) programs in BRICS countries were reviewed individually, showing the progress of Pharm D programs in each context. Evidence from developed countries indicates that Pharm D programs have contributed towards the positive development of public health and a country's local health requirements, with well-trained clinical pharmacists having a key role in the health and economic development of these emerging powers. The health systems of BRICS countries are heavily challenged with a dual burden of disease, weak health infrastructure and public health initiatives. Thus, not only will the development of Pharm D programs in BRICS countries strengthen pharmacy education contributing to a pharmacy workforce more readily able to target health-related problems, demographic and epidemiological shifts; but will also better equip public health systems with more patient-centered pharmaceutical care necessary for evidence-based, individualized and cost-effective healthcare.

The priority areas and possible pathways for health cooperation in BRICS countries

“…Despite the fact that BRICS countries have the world's largest emerging pharmaceutical markets and increasing consumption levels, they are still in a passive position in the global pharmaceutical industry. At the pharmaceutical Research and Development (R&D) stage, the capacity for innovative drug research is challenging to be improved in the short term due to the lack of accumulation of technology and talents [ 36 , 37 ]. Brazil’s lack of initiative in researching and producing vaccines during the COVID-19 pandemic was a wake-up call [ 38 ].…”